IAPs and Cell Death

John Silke1, James Vince2

  • 1The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, 3052, Australia. silke@wehi.edu.au.

Insights

Inhibitors of Apoptosis Proteins (IAPs) regulate multiple cell death types beyond apoptosis, including necroptosis and pyroptosis. Understanding IAPs offers new strategies for cancer therapy and inflammation control.

Area of Science:

  • Cell Biology
  • Immunology
  • Oncology

Background:

  • Inhibitors of Apoptosis Proteins (IAPs) were initially identified for their role in preventing programmed cell death (apoptosis).
  • Emerging evidence indicates IAPs also regulate other cell death pathways, such as necroptosis and pyroptosis.
  • Their involvement in cell death processes, particularly in cancer, has spurred interest in developing IAP inhibitors.

Purpose of the Study:

  • To discuss the multifaceted roles of IAPs in apoptosis, necroptosis, and pyroptosis.
  • To explore the connection between IAP-mediated cell death and inflammatory responses.
  • To highlight how IAP antagonists, developed for cancer therapy, have advanced our understanding of these processes.

Main Methods:

  • Literature review and synthesis of existing research on IAPs.
  • Analysis of IAP involvement across different programmed cell death paradigms.
  • Examination of the link between IAPs, cell death, and inflammation.

Main Results:

  • IAPs are key regulators not only of apoptosis but also of necroptosis and pyroptosis.
  • These cell death pathways are intrinsically linked to the modulation of inflammation.
  • IAPs play a direct role in regulating inflammatory processes.
  • IAP antagonist drugs have been instrumental in uncovering these broader functions.

Conclusions:

  • IAPs are crucial regulators of diverse cell death pathways, extending beyond apoptosis.
  • The interplay between IAPs, cell death, and inflammation is significant.
  • Targeting IAPs holds therapeutic potential for cancer and inflammatory diseases.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K